期刊文献+

S100A4 annexinA2组织蛋白酶B在乳腺癌组织中的表达及意义

Expression and significance of S100A4,annexinA2 and CathepsinB in breast carcinoma
原文传递
导出
摘要 目的探讨乳腺浸润性导管癌、正常乳腺组织和乳腺良性病变组织中S100A4、annexinA2、组织蛋白酶B的表达及三者与乳腺浸润性导管癌的浸润、转移的关系。方法免疫组织化学SP法检测。结果 S100A4蛋白、annexinA2蛋白及组织蛋白酶B蛋白在正常乳腺组织及乳腺良性病变组织中不表达或低表达,在乳腺浸润性导管癌中均高表达。结论①S100A4蛋白参与了乳腺浸润性导管癌的淋巴结转移,annexinA2蛋白和组织蛋白酶B参与了乳腺浸润性导管癌的浸润、淋巴结转移。②三者协同促进了乳腺浸润性导管癌的浸润和淋巴结转移,共同参与了肿瘤的浸润和转移。 Objective To investigate the expressions of S100A4,annexinA2,CB proteins in the breast invasive ductal carcinoma,breast normal tissues and benign breast lesions and their correlationship with invasion and metastasis.Methods Detected by immunohistochemistry SP.Results S100A4,annexinA2 and CB protein in normal breast tissue and breast benign lesions is no expression or low expresseion,but in breast invasive ductal carcinoma is high expression.Conclusions ①S100A4 protein involved in lymph node metastasis of breast invasive ductal carcinoma,annexinA2 protein and CB protein involved in invasion and lymph node metastasis of breast invasive ductal carcinoma.②In breast invasive ductal carcinoma,the expression of S100A4 and annexinA2 and CB protein was positively correlated,it implied they have certain synergy to promote invasion and lymph node metastasis of breast invasive ductal carcinoma,participate in tumor invasion and metastasis.
作者 李新 李道明
出处 《医药论坛杂志》 2011年第20期13-15,共3页 Journal of Medical Forum
关键词 钙结合蛋白S100A4 钙磷脂结合蛋白A2 组织蛋白酶B 乳腺浸润性导管癌 免疫组织化学 S100A4 annexinA2 CathepsinB breast invasive ductal carcinoma Immunohistochemistry
  • 相关文献

参考文献10

  • 1周晓彬,张健.中国女性被动吸烟与乳腺癌发病关系的Meta分析[J].中国临床康复,2006,10(16):6-8. 被引量:16
  • 2Fernandez - Fernandez MR, Veprintsev DB, Fersht AR. Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor [ J ]. Proc Natl Acad Sci USA, 2005,102( 13 ) : 4735-4740.
  • 3张新,李茂竹,张锋,李海兵.S100A4蛋白在乳腺癌中的表达和意义[J].中国医药指南,2009,7(5):3-4. 被引量:1
  • 4Dowling P, Meleady P, Dowd A, et al. Proteomic analysis of isolated membrane fractions from superinvasive cancer cells [ J ]. Biochim Biophys Acta, 2007, 1774 ( 1 ) :93-101.
  • 5Khan A, Krishna M, Baker SP, et al. Cathepsin B expression and its correlation with tumor - associated laminin and tumor progression in gastric cancer [ J ]. Arch Pathol Lab Med, 1998,122 (2):172-177.
  • 6Turk B, Turk D, Turk V. Lysosomal cysteine proteases : more than scavengers [ J ]. Biochim Biophys Acta, 2000, 1477(1 -2) : 98-111.
  • 7Turk V, Turk B, Guncar G, et al. Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer [ J ]. Adv Enzyme Regul, 2002,42 : 285- 303.
  • 8Mort JS, Buttle DJ. Cathepsin B [ J]. Int J Biochem Cell Biol, 1997,29 (5) : 715-720.
  • 9Semov A,Moreno MJ,Onichtchenko A, et al. Metasta- sisassociated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation[J]. J Biol chem, 2005, 280(21 ): 20833-20841.
  • 10Mai J, Finley RLJr, Waisman DM, et al. Human procathepsin B interacts with the annexin Ⅱ tetramer on the surface of tumor cells [ J ]. J Biol Chem, 2000,275 ( 17 ) : 12806-12812.

二级参考文献20

  • 1刘润幸,黄渭铭,郭贡年.女性乳腺癌危险因素的Logistic回归分析[J].肿瘤防治研究,1994,21(2):102-104. 被引量:22
  • 2王家良.临床流行病学(第2版)[M].上海:上海科学技术出版社,2001.259-260.
  • 3Madigan MP,Ziegler RG,Benichou J,et al.Proportion of breast cancer cases in the United States explained by well-established risk factors.J Natl Cancer Inst 1995;87(22):1681-5.
  • 4Lichtensiein MJ,Mulrow CD,Elwood PC.Guidelines for reading case-control studies.J Chron Dis 1987;40(9):893-903.
  • 5Begg CB,Mazumdar M.Operating characteristics of a rank correlation test for publication bias.Biometrics 1994;50(4):1088-101.
  • 6Li D,Wang M,Dhingra K,et al.Aromatic DNA adducts in adjacent issues of breast cancer pantients:Clues to breast cancer etiology.Cancer Res 1996;56(2):287-93.
  • 7Perera FP,Estabrook A,Hewer A,et al.Carcinogen-DNA adducts in human breast issues.Cancer Epidemiol Biomakers Prev 1995;4(3):233-8.
  • 8Petakis NL.Nipple aspirate fluid in epidemiological studies of breast disease.EpidemiolRev 1993;15(1):188-95.
  • 9Michnowicz JJ,Bradlow HL.Dietary and pharmacological control of estradiol metabolism in humans.Ann N Y Acid Sci 1990;595:291-9.
  • 10Lemon HM,Heidel JW,Rodriguez-Sierra JF.Increased catehcol estrogen metabolism as a risk factor for nonfamilial breast cancer.Cancer 1992;69(2):457-65.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部